Workflow
PHINIA (PHIN) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:30
Q2 2025 EARNINGS July 24, 2025 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical fact that provide current expectations or forecasts of future events based on certain assumptions and are not guarantees of future performance. Forward-looking statements use words such as "anticipate," "believe," "continue," "could," "designed," "effect," "estimate," "evaluate," "ex ...
CenterPoint Energy(CNP) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
Cautionary Statement and Other Disclaimer This presentation and the oral statements made in connection herewith contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact included in this presentation and the oral statements made in connection herewith are forward-looking statements made in good faith by CenterPoint Energy, Inc. ("CenterPoint Energy" or th ...
Dow(DOW) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
Financial Performance - Net sales reached $10.1 billion, while Operating EBITDA amounted to $703 million [7] - The company received approximately $2.4 billion in cash from the Diamond Infrastructure Solutions partnership, with a potential additional $600 million expected in the second half of 2025 [7] - A final judgment ruling awarded the company approximately $1.2 billion from the NOVA litigation, with cash inflow anticipated in the second half of 2025 [7] Cost Savings and Divestitures - The company announced two divestitures totaling approximately $250 million, at an operating EBITDA multiple of approximately 10x [7] - In-year cost savings are increasing to approximately $400 million, as part of a $1 billion program [7] Capital Allocation - A 50% dividend reduction was announced to prioritize a balanced capital allocation framework [7] - 2025 CapEx is being reduced to approximately $2.5 billion, which is approximately $1 billion lower than original plans [34] Segment Performance - Packaging & Specialty Plastics reported Op EBIT of $632 million, with margins up 1,130 bps YoY [9] - Industrial Intermediates & Infrastructure reported Op EBIT of $192 million, with margins up 680 bps YoY [18] - Performance Materials & Coatings reported Op EBIT of $6 million, with margins up 60 bps YoY [20] Outlook - 3Q25 Net Sales are expected to be ~$10.2B [29]
Allegion(ALLE) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
Financial Performance - Revenue increased by 5.8% to $1,022.0 million in Q2 2025, compared to $965.6 million in Q2 2024[18] - Adjusted EPS increased by 4.1% to $2.04 in Q2 2025, compared to $1.96 in Q2 2024[18] - Available Cash Flow (ACF) increased significantly by 56.5% to $275.4 million YTD Q2 2025, compared to $176.0 million YTD Q2 2024[21, 44] - The company is raising FY-2025 Adjusted EPS outlook to $8.00-$8.15[10, 55] Segment Performance - Allegion Americas revenue increased by 6.6% to $821.5 million in Q2 2025, compared to $770.7 million in Q2 2024[29] - Allegion International revenue increased by 2.9% to $200.5 million in Q2 2025, compared to $194.9 million in Q2 2024[36] - Americas organic revenue growth was 4.5% in Q2 and 4.7% YTD[26] - International organic revenue declined by 2.2% in Q2 and 0.7% YTD[26] Capital Allocation and Acquisitions - The company is accelerating capital deployment[10, 55] - Approximately $44 million was allocated for dividends, equating to $0.51 per ordinary share[12] - The company spent $40 million on share repurchases in Q2 2025[13] - The company announced acquisitions with a combined purchase price of approximately $525 million (€330M purchase price (~$390M) for technology & electronics acquisitions, ~$55M for mechanical portfolio expansion, and ~$80M for complementary software & services)[16] Outlook - The company updated its FY-2025 organic revenue growth outlook to 3.5% to 4.5%[50] - The company expects approximately $40 million of surcharge revenue in the Americas related to tariff mitigation, which is neutral to EPS[49]
Keurig Dr Pepper(KDP) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
Second Quarter 2025 Earnings Conference Call July 24, 2025 Safe Harbor and Non-GAAP Financial Measures Note Regarding Forward-Looking Statements: SUPPLY CHAIN | DEDICATED TRANSPORTATION | FLEET MANAGEMENT SOLUTIONS © 2025 Ryder System, Inc. All Rights Reserved Certain statements and information included in this presentation are "forward-looking statements" under the Federal Private Securities Litigation Reform Act of 1995, including our expectations regarding: our forecast; our outlook; market conditions, s ...
LKQ (LKQ) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
Forward Looking Statements and Non-GAAP Financial Measures Statements and information in this presentation that are not historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are made pursuant to the "safe harbor" provisions of such Act. Forward-looking statements include, but are not limited to, statements regarding our outlook, guidance, expectations, beliefs, hopes, intentions and strategies. These statements are subject to a number of ris ...
Nasdaq(NDAQ) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
7% Nasdaq Nasdaq 2Q25 Quarterly Update July 24, 2025 Disclaimers Cautionary Note Reqarding Forward-Looking Statements Information set forth in this sommunication contains forward-looking statements that involve a number of risks and uncertainties. Nasdap qoutions readers that any forward not a quarantee of future performance and that adval results could differ materialy from those contained in the forward-looking information. Mnen used in this communicati f'expects, "enables," "will," "plans," "adjusted", " ...
Textron(TXT) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
Q2 2025 Earnings Call Presentation July 24th, 2025 1 Forward-looking Information Certain statements in this package and other oral and written statements made by Textron from time to time are forward-looking statements, including those that discuss strategies, goals, outlook or other non-historical matters; or project revenues, income, returns or other financial measures. These forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any ...
ICON plc(ICLR) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
ICON plc Q2 2025 Results Period Ended June 30, 2025 Forward Looking Statement Statements included in this presentation which are not historical facts are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the "PSLRA"). Forward-looking statements include statements regarding our financial guidance and outlook, and may be identified by the use of future tense or other forward-looking words su ...
novocure(NVCR) - 2025 Q2 - Earnings Call Presentation
2025-07-24 12:00
Confidential © 2024 Novocu © 2025 re GmbH Novocure GmbH 1 © 20254 Novocure GmbH GmbH 4 © 2025 Novocure GmbH 2 2025 key objectives, unlocking TTFields potential | DRIVING COMMERCIAL | ADVANCING | DELIVERING | | --- | --- | --- | | ADOPTION | CLINICAL PIPELINE | PRODUCT INNOVATION | | ✔ NSCLC drive global active | ✔ PANOVA-3 present and | V Launch MyNovocure | | patient growth and | publish data | patient app | | pursue reimbursement | • PANOVA-3 submit to FDA, | • New array utilized by | | ✔ NSCLC CE Mark | ...